Koyfin Home > Directory > Health Care > Albireo Pharma Inc > Long-Term Debt / Capital

Albireo Pharma Inc Long-Term Debt / Capital Chart (ALBO)

Albireo Pharma Inc annual/quarterly Long-Term Debt / Capital from 2015 to 2020.
  • Albireo Pharma Inc Long-Term Debt / Capital for the quarter ending June 06, 2020 was $13m a 68.53% increase of 9m year over year
  • Albireo Pharma Inc Long-Term Debt / Capital for the last 12 months ending June 06, 2020 was $13m a 68.53% increase of 9m year over year
  • Albireo Pharma Inc Annual Long-Term Debt / Capital for 2019 was $4m a 13,633.16% increase of 583m from 2018
  • Albireo Pharma Inc Annual Long-Term Debt / Capital for 2015 was $-579m a 118.93% decrease of -688m from 2014
  • Albireo Pharma Inc Annual Long-Term Debt / Capital for 2014 was $110m
Other Ratios Metrics:
  • Albireo Pharma Inc Total Debt / Capital for the quarter ending September 09, 2017 was $2m a -268.92% decrease of -6m year over year
  • Albireo Pharma Inc Other Liabilities for the quarter ending December 12, 2018 was $50m a 8.86% increase of 4m year over year
  • Albireo Pharma Inc Total Debt / Equity for the quarter ending September 09, 2017 was $2m a -291.29% decrease of -6m year over year
View Chart On Koyfin

Quarterly ALBO Long-Term Debt / Capital Data

06/2020$13m
03/2020$3m
12/2019$4m
09/2019$4m
06/2019$0m
03/2019$0m
09/2016$-59m
06/2016$-238m
12/2015$-579m

Annual ALBO Long-Term Debt / Capital Data

2019$4m
2015$-579m
2014$110m